Open access
Aug 2026
Prognostic significance of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy
The androgen receptor (AR) is an emerging biomarker in breast cancer (BC), yet its prognostic relevance in patients undergoing neoadjuvant chemotherapy (NACT) remains inconclusive. While most studies focus on Western populations, data from the Caucasus are scarce. Given regional differences in tumor biology and treatme...
A. Aliyev, Adila Adilli, Aydan Ismayilsoy et al.
· Medicine · 0 citations